semaglutide maker FDA Sends Warning Letter to Ozempic Over Potential Unreported Side Effects Demand Rising for 'Bootlegged' Weight-Loss

Severe gastrointestinal complications can significantly disrupt daily life, often necessitating long-term medical care for affected individuals

Published online September 5, 2025

Acute Kidney Injury Due to Volume Depletion There have been postmarketing reports of acute kidney injury, in some cases requiring hemodialysis, in patients treated with semaglutide

Dulaglutide and semaglutide are prescribed for type 2 diabetes management, and semaglutide [in the form of Wegovy] is also approved for chronic weight management in patients with a BMI 30, or 27 with weight-related comorbidities. Trulicity vs

Collectively, these data show that GLP-1RA/tesaglitazar outperforms the GLP-1RA and tesaglitazar to decrease body weight and to improve glucose metabolism in mice with genetically induced obesity and glucose intolerance